Richard T Kenney is Chief Medical Officer of Sonnet BioTherapeutics Holdings Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sonnet BioTherapeutics Holdings, Inc.
17 Feb 23
4
Sonnet BioTherapeutics Holdings, Inc.
22 Dec 22
4
Sonnet BioTherapeutics Holdings, Inc.
9 Jun 21
4
Sonnet BioTherapeutics Holdings, Inc.
20 May 21
4
Sonnet BioTherapeutics Holdings, Inc.
1 Apr 21
3
Sonnet BioTherapeutics Holdings, Inc.
1 Apr 21
4
Immune Design Corp.
6 Jan 16
4
Immune Design Corp.
3 Nov 15
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jan 23 | SONN Sonnet BioTherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 14,627 | 0.00 | 18,198 |
7 Jan 23 | SONN Sonnet BioTherapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 14,627 | 0.00 | 3,571 |
14 Dec 22 | SONN Sonnet BioTherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 14,627 | 0.00 | 64,627 |